Wells Fargo’s Lifecore Biomedical LFCR Stock Holding History

Wells Fargo’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.1K	Sell	10,253 -20,504	-67%	-$142K	﹤0.01%	5548
2025 Q4	$252K	Buy	30,757 +12,632	+70%	+$93.4K	﹤0.01%	4936
2025 Q3	$133K	Buy	18,125 +2,902	+19%	+$22K	﹤0.01%	5164
2025 Q2	$124K	Buy	15,223 +92	+0.6%	+$620	﹤0.01%	5073
2025 Q1	$107K	Buy	15,131 +1,750	+13%	+$10.9K	﹤0.01%	5074
2024 Q4	$99.4K	Buy	13,381 +3,012	+29%	+$19.2K	﹤0.01%	5207
2024 Q3	$51.1K	Sell	10,369 -942	-8%	-$4.92K	﹤0.01%	5337
2024 Q2	$58K	Buy	11,311 +9,164	+427%	+$54.3K	﹤0.01%	5239
2024 Q1	$11.4K	Buy	2,147 +3	+0.1%	+$21	﹤0.01%	5726
2023 Q4	$13.3K	Buy	2,144 +10	+0.5%	+$69	﹤0.01%	5752
2023 Q3	$16.1K	Sell	2,134 -4	-0.2%	-$37	﹤0.01%	5675
2023 Q2	$20.7K	Sell	2,138 -4,466	-68%	-$27.3K	﹤0.01%	5726
2023 Q1	$24.9K	Buy	6,604 +4,654	+239%	+$25.9K	﹤0.01%	5547
2022 Q4	$12.6K	Sell	1,950 -63	-3%	-$519	﹤0.01%	5455
2022 Q3	$18K	Sell	2,013 -271	-12%	-$2.76K	﹤0.01%	5448
2022 Q2	$22K	Sell	2,284 -23,830	-91%	-$236K	﹤0.01%	5403
2022 Q1	$303K	Sell	26,114 -27,876	-52%	-$310K	﹤0.01%	4742
2021 Q4	$600K	Sell	53,990 -35,497	-40%	-$344K	﹤0.01%	4522
2021 Q3	$825K	Buy	89,487 +61,182	+216%	+$666K	﹤0.01%	4369
2021 Q2	$319K	Sell	28,305 -48,616	-63%	-$560K	﹤0.01%	4839
2021 Q1	$815K	Sell	76,921 -3,897	-5%	-$43.8K	﹤0.01%	4385
2020 Q4	$877K	Buy	80,818 +1,025	+1%	+$10.6K	﹤0.01%	4125
2020 Q3	$775K	Sell	79,793 -6,695	-8%	-$63.8K	﹤0.01%	4048
2020 Q2	$688K	Buy	86,488 +11,290	+15%	+$116K	﹤0.01%	4097
2020 Q1	$654K	Buy	75,198 +20,512	+38%	+$213K	﹤0.01%	3827
2019 Q4	$618K	Sell	54,686 -227,562	-81%	-$2.42M	﹤0.01%	4198
2019 Q3	$3.07M	Buy	282,248 +17,708	+7%	+$193K	﹤0.01%	2970
2019 Q2	$2.48M	Sell	264,540 -9,679	-4%	-$97.7K	﹤0.01%	3158
2019 Q1	$3.37M	Buy	274,219 +5,249	+2%	+$64.1K	﹤0.01%	2922
2018 Q4	$3.19M	Sell	268,970 -823	-0.3%	-$11.3K	﹤0.01%	2874
2018 Q3	$3.88M	Buy	269,793 +4,470	+2%	+$61.8K	﹤0.01%	2861
2018 Q2	$3.95M	Sell	265,323 -187	-0.1%	-$2.6K	﹤0.01%	2899
2018 Q1	$3.46M	Buy	265,510 +5,555	+2%	+$73K	﹤0.01%	2923
2017 Q4	$3.27M	Buy	259,955 +20,404	+9%	+$258K	﹤0.01%	2968
2017 Q3	$3.1M	Buy	239,551 +30,906	+15%	+$407K	﹤0.01%	2925
2017 Q2	$3.1M	Sell	208,645 -5,690	-3%	-$79.2K	﹤0.01%	2854
2017 Q1	$2.57M	Buy	214,335 +17,300	+9%	+$219K	﹤0.01%	2996
2016 Q4	$2.72M	Buy	197,035 +8,070	+4%	+$112K	﹤0.01%	2905
2016 Q3	$2.53M	Buy	188,965 +1,645	+0.9%	+$19.9K	﹤0.01%	2781
2016 Q2	$2.02M	Sell	187,320 -431	-0.2%	-$4.75K	﹤0.01%	2970
2016 Q1	$1.97M	Sell	187,751 -82,932	-31%	-$911K	﹤0.01%	2931
2015 Q4	$3.2M	Buy	270,683 +902	+0.3%	+$11.1K	﹤0.01%	2642
2015 Q3	$3.15M	Buy	269,781 +10,547	+4%	+$140K	﹤0.01%	2645
2015 Q2	$3.74M	Buy	259,234 +70,480	+37%	+$1.02M	﹤0.01%	2626
2015 Q1	$2.63M	Buy	188,754 +87,532	+86%	+$1.21M	﹤0.01%	2836
2014 Q4	$1.4M	Buy	101,222 +2,154	+2%	+$27.8K	﹤0.01%	3281
2014 Q3	$1.21M	Sell	99,068 -2,234	-2%	-$27.9K	﹤0.01%	3339
2014 Q2	$1.27M	Sell	101,302 -15,796	-13%	-$186K	﹤0.01%	3357
2014 Q1	$1.31M	Sell	117,098 -3,769	-3%	-$41.3K	﹤0.01%	3279
2013 Q4	$1.47M	Buy	120,867 +40,021	+50%	+$478K	﹤0.01%	3152
2013 Q3	$987K	Buy	80,846 +2,779	+4%	+$38.8K	﹤0.01%	3363
2013 Q2	$1.03M	Buy	+78,067	New	+$1.08M	﹤0.01%	3254

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return